Protective effects of hemin pretreatment combined with ulinastatin on septic shock in rats

Chinese Medical Journal

Volumn 121, Issue 1, 2008, Pages 49-55

  Yu, Jian Bo ^a   Yao, Shang Long ^b  

^a TIANJIN NANKAI HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Carbon oxide; Heme oxygenase; Hemin; Septic shock; Ulinastatin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; BETA GLUCURONIDASE; CARBON MONOXIDE; CREATININE; EVANS BLUE; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; MESSENGER RNA; NITROGEN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY; LIVER; LUNG; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTECTION; RAT; SEPTIC SHOCK; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

EID: 38349091381     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200801010-00010     Document Type: Article

References (25)

1. Macmicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650.
2. Koide M, Kawahara Y, Tsuda T, Yokoyama, M. Cytokine-induced expression of an inducible type of nitric oxide synthase, gene in cultured vascular smooth muscle cells. FEBS Lett 1993; 318:213-217.
3. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 1993; 22: 34-39.
4. Hauser B, Bracht H, Matejovic; M, Radermacher P, Venkatesh B. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 2005; 101: 488-498.
5. Chen X, Wu B, Wang J, Bai T. Mechanism of the protective effects of noninvasive limbs preconditioning on myocardial ischemia-reperfusion injury. Chin Med J 2005; 118: 1723-1727.
6. Keaney Jr JF, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J. Methylene blue reverses endotoxin-induced hypotension. Circ Res 1994; 74: 1121-1125.
7. Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol 2006; 69: 983-990.
8. Mayers I, Johnson D. Septic shock: treating more than just blood pressure. Can Med Assoc J 2000; 162: 369-370.
9. Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yushino S, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005; 67: 673-680.
10. Ryter SW, Alarn J, Choi Am. Herne oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
11. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247:3170-3175.
12. Ohkawa H, Ohishi N, Yagi K. Assay for tipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-257.
14. Chalmers AH. Simple, sensitive measurement of carbon monoxide in plasma. Clin Chem 1991; 37: 1442-1445.
15. Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, Sun H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasin in rats. J Clin Invest 1999; 104: 59-66.
16. Pellacani A, Wiesel P, Sharma A, Foster LC, Huggins GS, Yet SF, et al. Induction of heme oxygenase-1 during endotoxemia is downregulated by transforming growth factor-β. Circ Res 1998; 83: 396-403.
17. Masini E, Vannacci A, Marzocca C, Pierpaoli S, Giannini L, Fantappié O, et al. Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp Biol Med 2003; 228: 546-549.
18. Taille C, Foresti R, Lanone S, Zedda C, Green C, Aubier M, et al. Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am J Respir Crit Care Med 2001; 163: 753-761.
19. Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004; 66: 773-779.
20. Tamion F, Richard V, Bonmarchand G, Leroy J, Lebreton JP, Thuillez C. Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med 2001; 164: 1933-1938.
21. Sato Y, Ishikawa S, Otaki A, Takahashi T, Hasegawa Y, Suzuki M, et al. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. Jpn J Thorac Cardiovasc Surg 2000; 48: 428-434.
22. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001; 15: 101-105.
23. Xiao Z, Rong M, Zhi Y, Yong D, Xi F, Jing S. Protective effect of ulinastatin against ischemia-reperfusion injury in rat small bowel transplantation. Transplant Proc 2004; 36: 1564-1566.
24. Hashimoto K, Nomura K, Nakano M, Sasaki T, Kurosawa H. Pharmacological intervention for renal protection during cardiopuhnonary bypass. Heart Vessels 1993; 8: 203-110.
25. Huo GD, Cai SX, Chen B, Chen YH. Effects of serum of the rats ventilated with high tidal volume on endothelial cell permeability and therapeutic effects of ulinastatin. Chin Med J 2006; 119: 1374-1380.